HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 1,237-1,248 of 1,811
Drug study icon
CompletedNCT00393042

Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR

Official study title

Sleep and Tolerability of Extended Release Dexmethylphenidate vs. Mixed Amphetamine Salts: A Double Blind, Placebo Controlled Study (SAT STUDY)

This study has finished and is no longer accepting participants.

Multiple locations, including Chicago
ADHDMedication studyAges 9–17
Countries
United States
Sponsor
Seattle Children's Hospital
Other study type icon
TerminatedNCT00885560

SNAP 25 Gene Study

Official study title

Do People With ADHD, Who Respond Well to Amphetamine Medication But Not to Methylphenidate, Have Allelic Variants of the SNAP 25 Gene?

This study ended early.

In Vancouver
ADHDObservational studyAges 6+
Countries
Canada
Sponsor
University of British Columbia
Behavioral study icon
CompletedNCT02694939

STAND Community study

Official study title

Effectiveness of MI Enhanced Behavior Therapy for Adolescents With ADHD

This study has finished and is no longer accepting participants.

In Miami
ADHDBehavioural studyAges 11–17
Countries
United States
Sponsor
Florida International University
Drug study icon
CompletedNCT02795637

What the Body Does to the Drug for ADHD

Official study title

Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction

This study has finished and is no longer accepting participants.

Multiple locations, including Miami
ADHD, Eating disordersMedication studyAges 18–70
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Other study type icon
CompletedNCT03368690

Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder

Official study title

Effects of Polyphenolic Extract From Pine Bark on the Inattention and Hyperactivity in Patients With Attention Deficit Hyperactivity Disorder Based on the Antioxidative Status.

This study has finished and is no longer accepting participants.

Multiple locations, including New Taipei City
ADHDPlacebo comparisonAges 7–64
Countries
Taiwan
Sponsor
Taipei Medical University
Device study icon
UnknownNCT06069323

Therapeutic Use of rTMS in Pediatric ASD and ADHD Cohorts

Official study title

Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.

Current recruitment status is unconfirmed.

In Foggia
ADHDDevice studyAges 6–18
Countries
Italy
Sponsor
Ospedali Riuniti di Foggia
Other study type icon
CompletedNCT03437772

Third Generation Cognitive Behavioural Therapy vs Treatment-as-usual for ADHD

Official study title

Third Generation Cognitive Behavioural Therapy Versus Treatment-as-usual for Attention Deficit and Hyperactivity Disorder: a Randomized, 2-parallel-group, Evaluator Blinded, Superiority Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Montpellier
ADHDObservational studyAges 7–15
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Drug study icon
CompletedNCT07098585

To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.

Official study title

An Open Label, Randomized, Two-period, Two-treatment, Two-sequence, Crossover, Balanced, Single Dose Oral Bioequivalence Study in Healthy Adult Human Subjects Under Fasting Conditions.

This study has finished and is no longer accepting participants.

In Ahmedabad
ADHDMedication studyAges 18–55
Countries
India
Sponsor
Humanis Saglık Anonim Sirketi

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.